NCT00937846View on ClinicalTrials.gov

Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

July 15, 2009

Primary Completion Date

August 28, 2009

Study Completion Date

August 28, 2009

Conditions
Cognitive Disorders
Interventions
DRUG

GSK1034702

Single oral 5 mg dose in liquid formulation

Trial Locations (2)

NW10 7EW

GSK Investigational Site, London

W12 ONN

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00937846 - Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study | Biotech Hunter | Biotech Hunter